445 related articles for article (PubMed ID: 22509796)
1. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of drug transporters in the enterohepatic circulation.
Stieger B; Meier PJ
Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
[TBL] [Abstract][Full Text] [Related]
3. Ontogeny and drug metabolism in newborns.
Dotta A; Chukhlantseva N
J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
[TBL] [Abstract][Full Text] [Related]
4. Membrane transporters in drug development.
Keogh JP
Adv Pharmacol; 2012; 63():1-42. PubMed ID: 22776638
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
Feng B; Varma MV; Costales C; Zhang H; Tremaine L
Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
[TBL] [Abstract][Full Text] [Related]
6. Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.
Rodieux F; Gotta V; Pfister M; van den Anker JN
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S173-92. PubMed ID: 27385174
[TBL] [Abstract][Full Text] [Related]
7. An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs.
Phan VH; Tan C; Rittau A; Xu H; McLachlan AJ; Clarke SJ
Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1395-410. PubMed ID: 21950349
[TBL] [Abstract][Full Text] [Related]
8. Global patterns of genetic diversity and signals of natural selection for human ADME genes.
Li J; Zhang L; Zhou H; Stoneking M; Tang K
Hum Mol Genet; 2011 Feb; 20(3):528-40. PubMed ID: 21081654
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanisms.
Hirota T; Takane H; Higuchi S; Ieiri I
Curr Drug Metab; 2008 Jan; 9(1):34-8. PubMed ID: 18220569
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics: the inherited basis for interindividual differences in drug response.
Evans WE; Johnson JA
Annu Rev Genomics Hum Genet; 2001; 2():9-39. PubMed ID: 11701642
[TBL] [Abstract][Full Text] [Related]
11. Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
Yee SW; Brackman DJ; Ennis EA; Sugiyama Y; Kamdem LK; Blanchard R; Galetin A; Zhang L; Giacomini KM
Clin Pharmacol Ther; 2018 Nov; 104(5):803-817. PubMed ID: 29679469
[TBL] [Abstract][Full Text] [Related]
12. Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms.
König J
Handb Exp Pharmacol; 2011; (201):1-28. PubMed ID: 21103967
[TBL] [Abstract][Full Text] [Related]
13. Transporter assays as useful in vitro tools in drug discovery and development.
Volpe DA
Expert Opin Drug Discov; 2016; 11(1):91-103. PubMed ID: 26512742
[TBL] [Abstract][Full Text] [Related]
14. Genetic factors in drug metabolism.
Belle DJ; Singh H
Am Fam Physician; 2008 Jun; 77(11):1553-60. PubMed ID: 18581835
[TBL] [Abstract][Full Text] [Related]
15. Developmental pharmacokinetics.
van den Anker JN; Schwab M; Kearns GL
Handb Exp Pharmacol; 2011; 205():51-75. PubMed ID: 21882105
[TBL] [Abstract][Full Text] [Related]
16. [Effect of genetic polymorphism on the activity of drug transporters and its clinical significance].
Zhang HX; Wang LS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):765-9. PubMed ID: 18772522
[TBL] [Abstract][Full Text] [Related]
17. In vitro ADME phenotyping in drug discovery: current challenges and future solutions.
Williams JA; Bauman J; Cai H; Conlon K; Hansel S; Hurst S; Sadagopan N; Tugnait M; Zhang L; Sahi J
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):78-88. PubMed ID: 15679175
[TBL] [Abstract][Full Text] [Related]
18. PhRMA white paper on ADME pharmacogenomics.
Williams JA; Andersson T; Andersson TB; Blanchard R; Behm MO; Cohen N; Edeki T; Franc M; Hillgren KM; Johnson KJ; Katz DA; Milton MN; Murray BP; Polli JW; Ricci D; Shipley LA; Vangala S; Wrighton SA
J Clin Pharmacol; 2008 Jul; 48(7):849-89. PubMed ID: 18524998
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
20. Membrane transporters and drug development: relevance to pharmacogenomics, nutrigenomics, epigenetics, and systems biology.
Yan Q
Methods Mol Biol; 2010; 637():1-21. PubMed ID: 20419427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
